Strategy
Your data, distilled into a plan.
Findings across labs, wearables, genome, and medications, ranked by leverage. Owner, effort, and a clear validation window for each.
Plan progress
0 / 6
Top concern this week
Iron-deficient autonomic stress
Iron-deficient autonomic stress (H-001) · confidence 0.78
Ranked priorities
What matters most this week.
Tap to mark complete. Each item carries an owner and a validation window.
- Medical follow-upLow effortOwner · you + clinicianValidate in 56d
Recheck ferritin in 6–8 weeks (with or without supplementation)
Why · Ferritin is at 14 ng/mL — well below the 30 floor — and has been trending down for over a year. HRV has tracked the drop. This is the single highest-leverage finding in your data right now.
Action · Start 100 mg ferrous bisglycinate daily with vitamin C, on an empty stomach if tolerable. Re-test ferritin + CBC + reticulocytes in 8 weeks.
- Ferritin 14 ng/mL (↓38%)
- HRV ↓11%
- RHR ↑2%
- NutritionLow effortOwner · youValidate in 84d
Bridge vitamin D with 4,000 IU/day through winter
Why · Latest 25-OH vitamin D is 24 ng/mL — outside the deficient range, but below the 30 ng/mL threshold most clinicians use. Your GC + CYP2R1 variants suggest you respond well to supplementation.
Action · 4,000 IU vitamin D3 daily with a meal containing fat. Re-test in 8–12 weeks.
- 25-OH vit D 24 ng/mL
- GC + CYP2R1 'low responder' variants
- SleepLow effortOwner · youValidate in 14d
Move last caffeine of the day to before 2pm
Why · Your CYP1A2 genotype suggests slow caffeine clearance — a 3pm coffee is still ~50% on board at sleep onset. REM fragmentation has been increasing on Oura over the same window.
Action · Hard cut-off for caffeine at 2pm. Re-evaluate sleep architecture in 2 weeks; if REM continues to fragment, drop earlier.
- CYP1A2 slow metabolizer
- REM fragmentation ↑
- MovementMedium effortOwner · youValidate in 7d
Take a deload week before the next training block
Why · Strain rose 18% over baseline last week while recovery has held at 72% (the floor of your green zone). With HRV already suppressed by iron status, layering more load risks an upper-respiratory dip.
Action · Cut training volume by 40% for 7 days. Keep movement (Z2 cardio, mobility) but pull intensity. Watch HRV — if it climbs >65 ms during the deload, your hypothesis confirms.
- Strain 12.4 (↑18%)
- Recovery 72%
- HRV 58 ms
- Medical follow-upLow effortOwner · you + clinicianValidate in 84d
Re-test TSH in 12 weeks; add anti-TPO antibodies
Why · TSH has climbed from 1.6 → 4.5 mIU/L over four panels. You're still inside the lab range, but the trajectory matters and could indicate early Hashimoto's. Free T4 is normal so no urgency.
Action · Order TSH + Free T4 + anti-TPO + anti-Tg at next draw. If anti-TPO is positive, escalate to endocrinology; if negative, monitor.
- TSH 4.5 ↑22%
- Free T4 normal
- Medical follow-upLow effortOwner · clinicianValidate in 180d
Bring breast-cancer polygenic load to your next OB-GYN visit
Why · BCAC313 polygenic score sits at the 78th percentile for your ancestry-matched cohort. Combined with a Tyrer-Cuzick lifetime risk to be calculated by your clinician, this often shifts the recommended start of routine mammography earlier than 40.
Action · Print the genome dossier and discuss whether earlier screening (age 35) or annual breast MRI is appropriate. No urgency — long-term planning conversation.
- BCAC313 PGS · 78th %ile
- EUR-calibrated
Doctor visit · prep packet
Auto-generated questions to bring with you.
Each question is tied to specific data in your record. Print or share with your clinician.
Hematology
“Given my ferritin trend and HRV change, would you support a CBC + reticulocytes + iron panel re-test in 8 weeks, with or without iron supplementation in the meantime?”
Why I'm asking · Ferritin is the most actionable marker in my recent data. Knowing whether the doctor wants me to supplement before the recheck or not affects the trial design.
- Ferritin 14 ng/mL (↓38% over 1y)
- Iron 64 µg/dL (low)
- Transferrin sat 16% (low)
Endocrinology
“TSH has been climbing across my last four panels (1.6 → 4.5 mIU/L). Free T4 is normal. Should we add anti-TPO and anti-Tg at the next draw to rule out early Hashimoto's?”
Why I'm asking · Subclinical thyroid drift can show up this way years before becoming overt. If autoimmune, monitoring frequency changes.
- TSH 4.5 mIU/L (climbing)
- Free T4 1.1 ng/dL (normal)
- Free T3 3.0 pg/mL (normal)
Pharmacogenomics
“I'm a CYP2C19 *2/*2 poor metabolizer. If antiplatelet therapy is ever indicated, would you prescribe prasugrel or ticagrelor over clopidogrel? Anything else in your usual prescribing affected?”
Why I'm asking · CPIC level-A guideline. Worth flagging for my chart now so any future cardiologist sees it before reaching for clopidogrel.
- CYP2C19 *2/*2 poor metabolizer
- CPIC Level A guideline
Preventive
“My BCAC313 polygenic score for breast cancer is at the 78th percentile of my ancestry-matched cohort. Combined with my family history (TBD), would you recommend Tyrer-Cuzick risk modeling and possibly earlier mammography or breast MRI?”
Why I'm asking · Polygenic load can move the recommended screening start age. Want to plan ahead, not react.
- BCAC313 PGS · 78th %ile · EUR
- Discuss family history at visit
Visit summary
Next routine appointment within 6–8 weeks ideal
6 findings, ranked. Top concern is actionable today.